Herriot Tabuteau
Chief Executive Officer at Axsome Therapeutics. Based in New York, New York.
- Rank
- 270th of 14,452
- Companies held
- 1
- Largest holding
- AXSM, 100.0% of total
- Latest SEC filing
- Aug 6, 2026
What the $997M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Axsome Therapeutics AXSM Common Stock | Indirectly (see filing footnote) | 7,344,500 | $135.68 | $997M | 99.9% | Form 4, Aug 5, 2026 |
| Axsome Therapeutics AXSM Common Stock | Directly | 7,229 | $135.68 | $981K | 0.1% | Form 4, Aug 6, 2026 |
Share counts are the amounts Herriot Tabuteau reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | Sold | AXSM | 4,660 | $213.95 | $997K | View |
| Aug 5, 2026 | Sold | AXSM | 45,004 | $212.01 | $9.5M | View |
| Jul 1, 2026 | Sold | AXSM | 49,666 | $240.25 | $11.9M | View |
| Jun 9, 2026 | Sold | AXSM | 49,670 | $241.01 | $12.0M | View |
| Feb 2, 2026 | Sold | AXSM | 32,410 | $185.60 | $6.0M | View |
| Jan 7, 2026 | Sold | AXSM | 31,261 | $170.38 | $5.3M | View |
| Jan 6, 2026 | Sold | AXSM | 29,450 | $172.33 | $5.1M | View |
| Jan 5, 2026 | Sold | AXSM | 78,703 | $171.28 | $13.5M | View |
| Dec 4, 2025 | Sold | AXSM | 10,558 | $148.18 | $1.6M | View |
| Dec 3, 2025 | Sold | AXSM | 20,163 | $146.94 | $3.0M | View |
| Dec 2, 2025 | Sold | AXSM | 49,252 | $144.59 | $7.1M | View |
| Nov 5, 2025 | Sold | AXSM | 21,775 | $134.49 | $2.9M | View |
| Nov 4, 2025 | Sold | AXSM | 50,459 | $133.79 | $6.8M | View |
| Nov 3, 2025 | Sold | AXSM | 91,705 | $132.34 | $12.1M | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 267 | Ronald Clarke CEO & Chairman of BOD, Corpay. Atlanta, GA | $1.02B |
| 268 | William E. Conway, Jr Director, The Carlyle Group. Washington, DC | $1.02B |
| 269 | David M. Rubenstein Director, The Carlyle Group. Washington, DC | $1.02B |
| 270 | Herriot Tabuteau Chief Executive Officer, Axsome Therapeutics. New York, NY | $997M |
| 271 | Peter M. Bristow President, First Citizens BancShares. Raleigh, NC | $994M |
| 272 | Peter Doyle Director, Texas Pacific Land. New York, NY | $987M |
| 273 | Kr Sridhar Chairman & CEO, Bloom Energy. Redwood City, CA | $987M |
Other Axsome Therapeutics insiders
All AXSM insiders- Mark Coleman$58.9MDirector. #2267 overall
- Roger Jeffs$7.9MDirector. #1208 overall
- Nick Pizzie$5.9MChief Financial Officer. #12956 overall
Questions
How much stock does Herriot Tabuteau own?
Herriot Tabuteau holds $997,482,591 in listed stock based on SEC filings and current prices, mostly Axsome Therapeutics (AXSM). That ranks 270th on the Stock Rich List.
Is this Herriot Tabuteau's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Herriot Tabuteau last buy or sell stock?
The most recent open-market trade on file is a sale of 4,660 AXSM shares on Aug 6, 2026 at $213.95.